.svg)
Human-Relevant Discovery Begins With the Model: A Conversation With Shushant Jain
.png)
Building Human-Relevant Immuno Oncology Models: A Conversation With Ncardia’s Sanne Holt
Driving Predictive Science Forward: Inside the Shift Toward Human-Relevant Drug Discovery
Ncardia Acquires STAR-CRISPR Technology for Advanced Gene Editing of iPSCs
Unveiling Ncardia's Path to Innovation and Growth
.png)
Ncardia Welcomes Divisional CEO, Dr. Jeroen de Groot
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
